Pacira BioSciences, Inc. announced that after serving as an independent director for nine years, Yvonne Greenstreet, MBChB, is retiring from the company's Board of Directors effective March 31, 2023. Dr. Greenstreet is currently serving as Chief Executive Officer of Alnylam Pharmaceuticals, Inc. Pacira is initiating a process to identify an independent Board member to replace Dr. Greenstreet.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.38 USD | +3.26% | +14.64% | -9.96% |
10/05 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
08/05 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.96% | 141.41Cr | |
+29.98% | 68TCr | |
+30.34% | 59TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+7.09% | 17TCr |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira Biosciences Announces Yvonne Greenstreet to Retire from Board of Directors